Remedy Meds markets online weight-management care that includes compounded tirzepatide. Before comparing it with another provider, put three documents side by side: the proposed prescription, the complete payment schedule, and the rules for ending the plan.
We examined public provider pages and FDA sources on September 24, 2026. This is a research review, not a patient account or pharmacy inspection.
Request a written quote and the dispensing pharmacy details. A conditional money-back offer does not establish medical suitability or remove treatment risk.
Start with the service being described
Remedy advertises clinician access, medication delivery, and ongoing support. Those are descriptions of its program, not measurements of response time or the experience a particular patient will have. We did not create a medical account, obtain a prescription, or test a shipment.
Make the first conversation specific. Who reviews your history? Who answers a medication question after delivery? What happens if your usual clinician is unavailable? Keep those answers with your first-appointment notes, especially if your existing doctor will also be involved in your care.
Sources: Remedy Meds: Public program description · FDA: Managing medicine benefits and risks
Price the calendar, not just the headline
We could not establish a single current, universally applicable tirzepatide checkout price from the public pages reviewed. Older third-party price lists are not a substitute for a dated quote. Ask for the amount due now, renewal amount, term length, and any charge for supplies, laboratory work, or additional care.
The help center describes automatic billing every 28 days. Thirteen such periods span 364 days: a four-week rate should not be compared with a calendar-month rate by simply multiplying both by twelve. The June 2026 terms also describe prepaid subscription terms selected at checkout. Confirm which schedule applies to your actual offer. Our cost fieldnote gives you a place to start.
Sources: Remedy Meds: Initial payment and renewal timing · Remedy Meds: Billing inquiries, September 9, 2026 · Remedy Meds: Terms of Service, June 4, 2026
Separate cancellation from the weight-loss warranty
The terms require cancellation notice at least 48 hours before the subscription term ends and generally exclude refunds for the paid term. The help-center refund page separately promises an initial-payment refund if the clinician finds a new enrollee ineligible. Get that exception and the applicable dates confirmed before paying.
The warranty requires twelve uninterrupted months and thirteen shipments, among other conditions; brand-name medicines and microdosing are excluded. It is not a short trial or an unconditional refund. Read section 5 of the linked terms, including claim deadlines and evidence requirements. Save the version accompanying your purchase and ask for an explanation of any discrepancy with an advertisement.
Sources: Remedy Meds: Terms of Service, June 4, 2026 · Remedy Meds: Refund policy help article
Read the FDA letter in its proper time frame
FDA issued a warning letter to Remedy Meds on September 9, 2025 concerning marketing that implied its compounded semaglutide and tirzepatide were the same as approved products. That dated finding belongs in a provider review. We have not established the current resolution of the letter.
The letter does not test a particular patient’s vial or compare Remedy with CoreAge. For the clinical distinction, remember that compounded tirzepatide is not FDA-approved Zepbound or Mounjaro. Our compounding fieldnote explains why an ingredient reference cannot establish equivalent quality, safety, or effectiveness.
Sources: FDA: Remedy Meds warning letter, September 9, 2025 · FDA: Compounding questions and answers
Identify the pharmacy behind your prescription
Ask for the dispensing pharmacy’s full name, contact details, and relevant state license. Check the actual pharmacy assigned to you, not just a photograph or a general description of a pharmacy network. Ask whom to contact if the prescription, package, or instructions do not match what you were told.
FDA advises that compounded GLP-1 drugs be reserved for patients whose medical needs cannot be met by an approved drug. A clinician should explain the patient-specific rationale and current availability. Do not infer that a past national shortage authorizes every current order. Ask for that explanation before treating price as the deciding factor.
Sources: FDA: Buying medicines from online pharmacies · FDA: Concerns with unapproved GLP-1 drugs · FDA: GLP-1 supply and compounding policy
Prepare for questions after the first delivery
An understandable care plan should cover follow-up, the exact product supplied, and a route for reporting symptoms. Bring a medication list and relevant medical history rather than relying on a short advertising quiz to cover every issue. Approved tirzepatide labeling includes important contraindications and warnings that deserve a proper clinical discussion.
Ask the pharmacist to explain the label and handling instructions for your own prescription. This review does not supply a dose or switching schedule. The side-effect fieldnote outlines selected concerns and the difference between routine questions and symptoms needing prompt medical attention.
Sources: Lilly: Zepbound prescribing information · FDA: Managing medicine benefits and risks
Use the review as a comparison worksheet
Write down what remains unconfirmed: your actual price, the prescription, the pharmacy, the clinical contact route, and the exit terms. An unanswered question is a reason to ask for clarification, not evidence that a service has failed to provide it. Equally, a polished advertisement does not answer those questions for you.
The CoreAge review and Mochi review provide other public-offer summaries. For an approved-product access route, read the LillyDirect review. Bring the comparison to a clinician who can discuss which options are appropriate for you.
Sources: FDA: Managing medicine benefits and risks · FDA: Buying medicines from online pharmacies
The source shelf
- Remedy Meds: Public program description
Provider marketing checked September 24, 2026; no enrollment, prescription, shipment, or outcome was independently tested.
- FDA: Managing medicine benefits and risks
General questions for clinical decision-making and medication follow-up.
- Remedy Meds: Initial payment and renewal timing
Help article describes payment at sign-up, a 28-day cycle and refill forms. Selected checkout terms may differ.
- Remedy Meds: Billing inquiries, September 9, 2026
Recent help article repeats the 28-day billing cycle. It does not verify a personalized price.
- Remedy Meds: Terms of Service, June 4, 2026
Section 5: subscription terms, cancellation and conditional 12-month warranty. Checked September 24, 2026; read the terms accompanying the selected offer.
- Remedy Meds: Refund policy help article
January 2026 help article describes an initial clinical-ineligibility refund exception; reconcile with current checkout terms.
- FDA: Remedy Meds warning letter, September 9, 2025
Dated FDA finding about misleading compounded-product marketing. Read September 24, 2026; present resolution was not established.
- FDA: Compounding questions and answers
Compounded medicines do not undergo FDA premarket review like approved drugs.
- FDA: Buying medicines from online pharmacies
Checks for prescription requirements, licensing, contact details and pharmacy support.
- FDA: Concerns with unapproved GLP-1 drugs
Current FDA page read October 5, 2026. Compounding, dose and ingredient concerns; individual medical need does not establish automatic eligibility or equivalence.
- FDA: GLP-1 supply and compounding policy
Shortage resolution and restrictions on essentially copies; availability requires current professional assessment.
- Lilly: Zepbound prescribing information
Current manufacturer label read October 5, 2026: approved weight-management and moderate-to-severe OSA uses in specified adults; product-specific contraindications and instructions. Does not establish compounded-product equivalence.
